Comparisons between healthy and tumor endothelium have shown that tumor-associated endothelial caveolae selectively recruit Annexin A1, thereby allowing for targeted uptake of conjugated antibodies into tumors but not normal parenchymal tissue (Oh et al., 2014). The gene discussed is ANXA1; the disease is neoplasm.